| HOME >> BIOLOGY >> TECHNOLOGY |
-FINANCIAL TABLES FOLLOW-
CHINA-BIOTICS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited; Amounts expressed in US Dollars)
Three months ended Nine months ended
December 31, December 31,
2006 2007 2006 2007
Net sales $8,763,150 $11,931,306 $22,233,151 $29,266,801
Cost of sales (2,510,544) (3,183,056) (6,519,647) (8,039,651)
Gross profit $6,252,606 $8,748,250 $15,713,504 $21,227,150
Operating
expenses:
Selling expenses $(1,044,175) $(1,752,637) $(3,266,162) $(4,630,916)
General and
administrative
expenses (584,020) (1,258,927) (1,374,744) (3,155,544)
Total operating
Expenses $(1,628,195) $(3,011,564) $(4,640,906) $(7,786,460)
Income from
Operations $4,624,411 $5,736,686 $11,072,598 $13,440,690
Other income and
expenses:
Other income $37,864 $118,064 $142,242 $190,006
Other expenses (50,731) (384,212) (89,476) (404,147)
Total other income
(expenses) $(12,867) $(266,148) $52,766 $(214,141)
Income before
taxes $4,611,544 $5,470,538 $11,125,364 $13,226,549
Provision for
income taxes (1,009,310) (1,426,789) (3,066,112) (3,672,434)
Net income $3,602,234 $4,043,749 $8,059,252 $9,554,115
Earnings per
share:
Basic $0.21 $0.24 $0.47 $0.56
Diluted $0.21 $0.23 $0.47
'/>"/>
| SOURCE China-Biotics, Inc. Copyright©2008 PR Newswire. All rights reserved |